Skip to content
20-F

Annual Report (Foreign)

CORDOVACANN CORP. LVRLF

0001654954-22-016528

← back to feed
Filed
Dec 15, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Jun 30, 2022 109.5M sh
Cash And Equivalents FY 2022 · Jun 30, 2021 1.06M
Current Liabilities FY 2022 · Jun 30, 2021 6.85M
Total Liabilities FY 2022 · Jun 30, 2021 9.96M
Current Assets FY 2022 · Jun 30, 2021 2.13M
Total Assets FY 2022 · Jun 30, 2021 17.27M
Operating Cash Flow restated FY 2022 · Jun 30, 2020 −946.91K
Net Income FY 2022 · Jun 30, 2020 −4.65M
Gross Profit FY 2022 · Jun 30, 2020 60.03K
Cost Of Revenue restated FY 2022 · Jun 30, 2020 106.74K
Revenue FY 2022 · Jun 30, 2020 166.77K
Stockholders Equity FY 2022 · Jun 30, 2019 362.57K